Advanced search
Publication Cover
Risk Management and Healthcare Policy Volume 13, 2020 - Issue
Submit an article Journal homepage
98
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Management Strategies for Patients After CABG Surgery in the Outbreak of the COVID-19 Pandemic

Xiaogang Wang1 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2459-2672View further author information
ORCID Icon,
Yangzhao Zhou1 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, People’s Republic of China;2 Department of Medicine, University of California San Diego, La Jolla, CA92093, USAView further author information
,
Xia Zhang1 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, People’s Republic of ChinaView further author information
,
Jianming Li1 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, People’s Republic of ChinaView further author information
,
Xinmin Zhou1 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, People’s Republic of ChinaView further author information
&
ZhiWei Zhang1 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, People’s Republic of China;2 Department of Medicine, University of California San Diego, La Jolla, CA92093, USACorrespondence[email protected]
View further author information
Pages 1655-1659 | Published online: 21 Sep 2020

References

  • Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-931986257
  • Chinese Center of Disease Control and Prevention. Epidemic update and risk assessment of 2019 novel coronavirus; 2020.
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.264832091533
  • Chinese Center of Disease Control and Prevention. Available from: http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/. Accessed 71, 2020.
  • Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation. 2003;108(13):1655–1661. doi:10.1161/01.CIR.0000089189.70578.E214517152
  • Sousa-Uva M, Neumann FJ, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019;55:4–90.30165632
  • Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997. doi:10.1001/jama.288.23.298112479763
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-69742976
  • Group AC, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.18539916
  • Turnbull F, Neal B, Algert C, et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410–1419.15983291
  • Mayumi H, Zhang QW, Nakashima A, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg. 1997;63:129–137.8993254
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
  • Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352–2371. doi:10.1016/j.jacc.2020.03.03132201335
  • Kernis SJ, Harjai KJ, Stone GW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol. 2004;43(10):1773–1779. doi:10.1016/j.jacc.2003.09.07115145098
  • Mavioglu HL, Unal EU, Askin G, Kucuker SA, Ozatik MA. Perioperative planning for cardiovascular operations in the COVID-19 pandemic. Turk Gogus Kalp Damar Cerrahisi Derg. 2019;28(2):236–243. doi:10.5606/tgkdc.dergisi.2020.0929432551151
  • Patel V, Jimenez E, Cornwell L, et al. Cardiac surgery during the coronavirus disease 2019 pandemic: perioperative considerations and triage recommendations. J Am Heart Assoc. 2020;9(13):e017042. doi:10.1161/JAHA.120.01704232418460

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.